Disclosures for "Sex Differences for Verbal Fluency Decline in Progressive Supranuclear Palsy")
-
Mr. Digma has nothing to disclose.
-
Dr. Quijano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
-
Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
-
Dr. Bayram has nothing to disclose.